Trump’s Psychedelics Executive Order: What it changes and why it matters

Trump's psychedelics executive order is framed as a policy shift that could accelerate or expand psychedelic research and regulation. The focus is on what the order targets, how it may affect agencies, and what practical consequences it could have for clinical studies, market access, and state level activity. The discussion also situates the move within broader US drug and mental health policy trends, treating the order as a potential signal for future governance of psychedelics.